Antengene Corporation Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 6996.HK | RCUS | AAPG | SNDX | 688062.SS | 8SJ.F | |
|---|---|---|---|---|---|---|
| Market cap | 1.80B | 2.40B | 1.41B | 940.80M | 10.13B | 1.84B |
| P/E (TTM) | 32.8 | — | — | — | — | — |
| Forward P/E | -2.5 | -6.1 | -23.3 | -14.4 | -21.6 | — |
| Price/book | 1.7 | 3.8 | 16.9 | -54.7 | 14.1 | 2.4 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −43.69% | −1.28% | −53.43% | −28.86% | −51.34% | −37.59% |
| Today | +4.98% | −1.32% | +11.75% | −26.87% | +5.29% | +1.70% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All 6996.HK news ›XPOVIO® (selinexor) Approved for Commercialization in Indonesia, Further Expanding Antengene's Commercial Presence in APAC
05 Mar, 2025, 13:00 CST - XPOVIO® is the first and only approved XPO1 inhibitor in Indonesia. - From the second half of 2024 to now, XPOVIO® was successively approved in Thailand, Malaysia and Indonesia, significantly expanding Antengene's…
Antengene Presents Latest Clinical Results for ATG-022 and ATG-037 at ESMO 2026
Details of the Poster Presentations Title: ATG-022, a Claudin 18.2 ADC, in Advanced Gastric and Gastroesophageal Junction Cancer (CLINCH): Phase 2 Results Date: October 25, 2026 Time: 12:00PM-12:45PM (Central European Time) 7:00PM-7:45PM…
Merck Healthcare Korea names ex-Antengene exec Lee Dong-yeol medical affairs head
Merck Healthcare Korea announced the appointment of Lee Dong-yeol, former country medical director at Antengene Korea, as head of medical affairs, effective Monday. According to the company, Lee earned his medical degree from Kyung Hee…
Antengene to Present Latest Preclinical Results of Novel Cos-TCE Platform in Rapid Oral Abstract Presentation at SITC 2026
Details of the Poster Presentation Rapid Oral Abstract Presentation Presenting Author: Dr. Bing Hou, Antengene's Chief Scientific Officer Topic Selection: Rapid Oral - Basic 1 Date: Friday, November 6, 2026 Time: 12:30 PM - 01:30 PM…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- koreabiomed.com1
- prnewswire.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.